ArticleCureus2024
Impact of Green Tea Consumption on Postoperative Ileus in Colon Cancer Patients: A Pilot Randomized Controlled Trial.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of non-pharmacological interventions for the restoration of postoperative intestinal motility of patients with colorectal cancer: a systematic review and meta-analysis of randomized controlled trials.International journal of colorectal disease · 2025Pooled it
- Progress of traditional Chinese medicine in the prevention and treatment of colorectal cancer.World journal of gastrointestinal oncology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction The consumption of caffeine-rich green tea has been shown to promote recovery of postoperative gastrointestinal function after subtotal gastrectomy. However, the beneficial effects of green tea on colon cancer have not been clarified. This pilot study aimed to evaluate the impact of green tea intake on postoperative outcomes after colon cancer surgery. Method This study describes the findings of a single-center stratified randomized controlled trial. Colon cancer patients who underwent laparoscopic or restorative colon resection were randomly assigned to a postoperative green-tea-drinking or water-drinking group. The primary outcome was time to first defecation (hours). Secondary outcomes were the length of hospital stay, postoperative ileus, postoperative complications, mean daily fluid intake (mL), and the incidence of all adverse events. The protocol was registered with UMIN (UMIN000048174). Results A total of 18 patients were enrolled and eight were assigned to the green-tea-drinking and 10 to the water-drinking group. Patient characteristics were similar in both groups. The time to first defecation was 42.0 ± 21.8 hours in the green-tea-drinking and 49.4 ± 42.2 hours in the water-drinking group (p=0.79). There were also no significant differences in postoperative hospital stay (p=0.28) or mean daily fluid intake (p=0.07). In the green-tea-drinking group, one patient developed postoperative ileus, and another experienced pseudogout, showing no significant difference compared with the water-drinking group (p=0.09). Conclusions In this pilot single-center stratified randomized controlled trial, drinking either green tea or water after laparoscopic or open colon cancer surgery was safe and made no difference to the primary or secondary outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.